RKDA is currently covered by 1 analysts with average potential upside of $2.22 (58.73%) backed by 1 price targets and 8 ratings. Documented since 17-Aug-2020. Analyst's average stock valuation to be materialised ratio is 100% with an average time for price targets to be met of 750 days.
Most recent stock forecast was given by RAGHURAM SELVARAJU from HCWAINWRIGHT on 10-Jan-2022.
Highest price target for RKDA is 3, Lowest price target is 1, average price target is 2.
Currently, out of the existing stock ratings of RKDA - 6 which are a Buy (100%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
1 years 2 months 19 days ago
1/1 (100%)
$2.22 (58.73%)
750
What is RKDA(Arcadia Biosciences, Inc) average time for price targets to be met?
Which analyst has the current highest performing score on RKDA(Arcadia Biosciences, Inc) with a proven track record?
